Sutro Biopharma Inc (NASDAQ: STRO) is -22.61% lower on its value in year-to-date trading and has touched a low of $2.01 and a high of $6.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The STRO stock was last observed hovering at around $3.40 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $3.32, the stock is -21.22% and -18.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.65 million and changing -2.35% at the moment leaves the stock -18.92% off its SMA200. STRO registered -0.30% loss for a year compared to 6-month gain of -20.57%. The firm has a 50-day simple moving average (SMA 50) of $4.0442 and a 200-day simple moving average (SMA200) of $4.0945.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -33.06% loss in the last 1 month and extending the period to 3 months gives it a 13.12%, and is -15.95% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.39% over the week and 8.54% over the month.
Sutro Biopharma Inc (STRO) has around 302 employees, a market worth around $272.11M and $169.36M in sales. Profit margin for the company is -73.48%. Distance from 52-week low is 65.59% and -45.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.07%).
Sutro Biopharma Inc quarterly earnings per share for the current quarter are estimated at -0.73 with sales reaching $15.29M over the same period.The EPS is expected to shrink by -66.03% this year, but quarterly earnings will post -57.00% year-over-year.
170.0 institutions hold shares in Sutro Biopharma Inc (STRO), with institutional investors hold 78.89% of the company’s shares. The shares outstanding are 81.96M, and float is at 75.85M with Short Float at 3.95%. Institutions hold 78.13% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 6.91 million shares valued at $20.25 million. The investor’s holdings represent 11.2447 of the STRO Shares outstanding. As of 2024-06-30, the second largest holder is SUVRETTA CAPITAL MANAGEMENT, LLC with 7.71 million shares valued at $22.59 million to account for 9.4906 of the shares outstanding. The other top investors are MILLENNIUM MANAGEMENT LLC which holds 4.36 million shares representing 7.0974 and valued at over $12.78 million, while VANGUARD GROUP INC holds 5.785 of the shares totaling 3.56 million with a market value of $10.42 million.
Sutro Biopharma Inc (STRO) Insider Activity
The most recent transaction is an insider sale by Vasquez Nicki, the company’s CHIEF PORT. STRAT & ALNCE OFCR. SEC filings show that Vasquez Nicki sold 12,185 shares of the company’s common stock on Jan 29 ’24 at a price of $5.00 per share for a total of $60925.0. Following the sale, the insider now owns 12803.0 shares.
